|
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study |
Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC, Ramsey SD |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC, Ramsey SD. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Annals of Internal Medicine 2014; 160(9): 594-602 Indexing Status Subject indexing assigned by NLM MeSH Aged; Breast Neoplasms /epidemiology; Cardiovascular Diseases /epidemiology /prevention & Clinical Trials as Topic /economics; Colorectal Neoplasms /epidemiology; Cost Savings; Decision Support Techniques; Estrogen Replacement Therapy; Female; Financing, Government; Fractures, Bone /epidemiology; Health Expenditures; Humans; Incidence; Markov Chains; Middle Aged; National Institutes of Health (U.S.); Osteoporosis, Postmenopausal /complications /epidemiology /prevention & Postmenopause; Quality-Adjusted Life Years; United States; Women's Health /economics; control; control AccessionNumber 22014027532 Date bibliographic record published 29/10/2014 |
|
|
|